MyFinsight
Home
Blog
About
Back
Income Statement
Processa Pharmaceuticals, Inc. (PCSA)
Processa Pharmaceuticals, Inc. (PCSA)
source: myfinsight.com
Net loss
-$3,265,494
(16.99%↑ Y/Y)
Operating loss
-$2,336,138
(40.87%↑ Y/Y)
Total other income
expenses
-$929,356
General and
administrative expenses
$1,686,261
(12.16%↑ Y/Y)
Research and development
expenses
$649,877
(-73.44%↓ Y/Y)
Unrealized loss on digital
assets
$768,348
Realized loss on digital
assets
$159,005
Interest (expense)
income, net
-$2,003
Back